Clayton Trier - Jun 2, 2021 Form 4 Insider Report for U S PHYSICAL THERAPY INC /NV (USPH)

Role: Director
Signature: /s/ Clayton Trier
Stock symbol: USPH
Transactions as of: Jun 2, 2021
Transactions value $: -$299,785
Form type: 4
Date filed: 6/4/2021, 12:10 PM
Previous filing: May 27, 2021
Next filing: May 18, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	USPH	Common Stock	Sale	-$290K	-2.42K	-21.07%	$119.92	9.06K	Jun 2, 2021	Direct	F1, F2
transaction	USPH	Common Stock	Sale	-$3.24K	-27	-0.3%	$119.95	9.03K	Jun 3, 2021	Direct	F2
transaction	USPH	Common Stock	Sale	-$6.46K	-54	-0.6%	$119.62	8.98K	Jun 3, 2021	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price ($119.92). The shares were sold in multiple transactions at prices ranging from $119.91 to $119.99 per share, inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
F2	Includes 1,480 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares on each of July 1, 2021, October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates.

Content

The price reported is a weighted average price ($119.92). The shares were sold in multiple transactions at prices ranging from $119.91 to $119.99 per share, inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Includes 1,480 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares on each of July 1, 2021, October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates.